Healthtech Series B Investors & VC Firms
1027 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.
HCS Capital
MiamiSeed–Series B
5 people
Ballad Ventures
Johnson CityPre-Seed–Series B$500K – $1.5M
2 people
Semillero Partners
San JuanSeed–Series B$2.5M
4 people
Ambit Health Ventures
BostonSeed–Series B
3 people
INP Capital
VancouverSeed–Late Stage
6 people
Alium Capital
SydneySeed–Late Stage
5 people
Anchor Capital
BostonSeed–Late Stage
11 people
Roadmap Capital Inc.
TorontoSeed–Late Stage
5 people
Cencora Ventures
San FranciscoSeed–Series B$1M – $10M
1 person
NCL Technology Ventures Ltd.
LondonSeed–Series B
4 people
University Associates Venture Capital
TucsonSeed–Growth
4 people
AddVentures by SCG
BangkokSeed–Growth
6 people
Colorcon Ventures
Seed–Series B$500K – $2.5M
Hunniwell Lake Ventures LLC
Palo AltoSeed–Series B
6 people
Muirwoods Ventures
SeoulSeed–Late Stage
Jaza Rift Ventures
NairobiPre-Seed–Series B$50K – $2M
1 person
AXIS Participaciones Empresariales
MadridSeed–Late Stage$810K – $43.2M
4 people
MPCi (formerly Matrix Partners China)
SingaporeSeed–Growth
13 people
UNIQA Ventures GmbH
ViennaSeed–Series B$1.1M – $5.4M
7 people
dsm-firmenich Venturing
MaastrichtSeed–Growth$108K – $5.4M
9 people
Spruce Capital Partners
South San FranciscoSeries A–Growth
3 people
Tamarisc Ventures
Seed–Series B
4 people
Curious Capital
Pre-Seed–Growth
5 people
Highbury Holdings
SeattleSeed–Series B$100K – $10M
2 people
Related lists
Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Series B Investors & VC Firms (2946)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)Series B Investors & VC Firms in North America (1736)Series B Investors & VC Firms in United States (1571)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1357)
Data sourced from public filings and firms' own websites — see our methodology.


































































